A. Roberts

Most-cited papers

1. The Comparative Effects of Azilsartan Medoxomil and Olmesartan on Ambulatory and Clinic Blood Pressure

   G. Bakris, D. Sica, M. Weber, W. White +4 more

   2011The Journal of Clinical Hypertension144 citations Open access

   Semantic Scholar

   Save

2. Azilsartan Medoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic Hypertension

   W. Cushman, G. Bakris, W. White, M. Weber +4 more

   2012HYPERTENSION62 citations Open access

   Semantic Scholar

   Save

3. Blood Pressure–Lowering Efficacy of the Fixed‐Dose Combination of Azilsartan Medoxomil and Chlorthalidone: A Factorial Study

   D. Sica, G. Bakris, W. B. White, Michael A. Weber +4 more

   2012The Journal of Clinical Hypertension44 citations Open access

   Semantic Scholar

   Save

4. Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension

   M. Weber, W. White, D. Sica, G. Bakris +3 more

   2014Blood Pressure Monitoring13 citations Open access

   Semantic Scholar

   Save

5. Safety and Tolerability of Subcutaneous Methotrexate in Routine Clinical Practice

   Christien K. H. Li, K. Baker, T. Jones, Elizabeth J Coulson +2 more

   2020Arthritis care & research12 citations Open access

   Semantic Scholar

   Save

6. A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension

   W. Cushman, G. Bakris, W. White, M. Weber +4 more

   2018Journal of Hypertension10 citations Open access

   Semantic Scholar

   Save

7. Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study

   Alison Handley, E. Lloyd, A. Roberts, Bruce Barger

   2016Clinical and experimental hypertension8 citations Open access

   Semantic Scholar

   Save

8. A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone

   M. Weber, P. Sever, A. Juhasz, A. Roberts +1 more

   2018Journal of the Renin-Angiotensin-Aldosterone System5 citations Open access

   Semantic Scholar

   Save

9. Safety, Tolerability, and Efficacy of Azilsartan Medoxomil With or Without Chlorthalidone During and After 8 Months of Treatment for Hypertension

   M. Kipnes, Alison Handley, E. Lloyd, Bruce Barger +1 more

   2015The Journal of Clinical Hypertension5 citations Open access

   Semantic Scholar

   Save

10. SAT0235 Subcutaneous methotrexate is safer and more effective than oral methotrexate alone and in combination

    K.-H.-C. Li, T. Jones, M. Grove, A. Roberts +1 more

    2018Saturday, 16 JUNE 20180 citations Open access

    Semantic Scholar

    Save

11. Faster uptake of biosimilars could save NHS money

    A. Roberts

    2015PharmacoEconomics & outcomes news0 citations

    Semantic Scholar

    Save

12. AZILSARTAN MEDOXOMIL/CHLORTHALIDONE FIXED-DOSE COMBINATION LOWERS BP MORE THAN OLMESARTAN/HYDROCHLOROTHIAZIDE FIXED-DOSE COMBINATION IN STAGE 2 SYSTOLIC HYPERTENSION: LB3.4

    W. Cushman, G. Bakris, W. White, M. Weber +4 more

    20110 citations

    Semantic Scholar

    Save

13. FIXED-DOSE COMBINATION OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE PROVIDES SUPERIOR BP REDUCTION TO MONOTHERAPIES IN STAGE 2 HYPERTENSION: PP.14.382

    D. Sica, G. Bakris, W. White, M. Weber +4 more

    20110 citations

    Semantic Scholar

    Save

14. EFFICACY AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE WITH OLMESARTAN/HYDROCHLOROTHIAZIDE COMBINATIONS IN STAGE 2 SYSTOLIC HYPERTENSION: 4A.09

    W. Cushman, D. Sica, G. Bakris, M. Weber +4 more

    20110 citations

    Semantic Scholar

    Save